Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance. (2022)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkac038
PubMed Identifier: 35170719
Publication URI: http://europepmc.org/abstract/MED/35170719
Type: Journal Article/Review
Volume: 77
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 5
ISSN: 0305-7453